ESTEMIQ Trademark

Trademark Overview

On Tuesday, November 26, 2019, a trademark application was filed for ESTEMIQ with the United States Patent and Trademark Office. The USPTO has given the ESTEMIQ trademark a serial number of 88706726. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 26, 2023. This trademark is owned by Wyeth LLC. The ESTEMIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
estemiq

General Information

Serial Number88706726
Word MarkESTEMIQ
Filing DateTuesday, November 26, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 26, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 31, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 3, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWyeth LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017
Party NameWyeth LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, June 26, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 26, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 17, 2022SOU EXTENSION 5 GRANTED
Thursday, October 6, 2022SOU EXTENSION 5 FILED
Monday, October 17, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 6, 2022TEAS EXTENSION RECEIVED
Saturday, April 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 31, 2022SOU EXTENSION 4 GRANTED
Thursday, March 31, 2022SOU EXTENSION 4 FILED
Thursday, March 31, 2022TEAS EXTENSION RECEIVED
Saturday, October 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 30, 2021SOU EXTENSION 3 GRANTED
Thursday, September 30, 2021SOU EXTENSION 3 FILED
Thursday, September 30, 2021TEAS EXTENSION RECEIVED
Wednesday, March 31, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 29, 2021SOU EXTENSION 2 GRANTED
Monday, March 29, 2021SOU EXTENSION 2 FILED
Monday, March 29, 2021TEAS EXTENSION RECEIVED
Wednesday, October 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 19, 2020SOU EXTENSION 1 GRANTED
Monday, October 19, 2020SOU EXTENSION 1 FILED
Monday, October 19, 2020TEAS EXTENSION RECEIVED
Friday, October 16, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 16, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 16, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, October 16, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 16, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 16, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 26, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 31, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 31, 2020PUBLISHED FOR OPPOSITION
Wednesday, March 11, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 26, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 20, 2020ASSIGNED TO EXAMINER
Tuesday, December 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 29, 2019NEW APPLICATION ENTERED

Related Keywords

estemiq preparations disorders pharmaceutical dysfunction treatment liver erectile blood viral urological